Introduction: The superior vena cava (SVC) can act as an origin of atrial fibrillation (AF). The complex structure and special conductive properties of the SVC can result in complicated atrial tachycardia (AT), atrial flutter, or AF.
Introduction
Atrial fibrillation (AF) is a commonly observed arrhythmia in the clinic, which often causes clinical complications such as stroke and heart failure, corresponding to a high rate of morbidity and mortality. Studies have shown that most AF originates from the pulmonary vein (PV) and that circumferential pulmonary vein isolation (CPVI) could cure approximately 70% of cases. [1] In addition, there are numerous studies suggesting that other special anatomical structures, such as the superior vena cava (SVC), Marshall ligament, crista terminalis, coronary sinus (CS), and the left and right atrial appendage, could also be sites of origin of AF. [2, 3] We report a case of AF originating from the SVC, which demonstrated various atrial arrhythmias and was misdiagnosed as multiorigin AF.
Case presentation
A 53-year-old male patient with a 3-year history of tachycardia was admitted to our center for an electrophysiological (EP) study. Standard informed consent was given before the EP study. Standard CS leads (St. Jude Medical, St. Paul, Minnesota) were placed as shown in Figure 1A ; the baseline intracardial electrocardiogram showed a normal sinus rhythm during the programmed stimulation. However, after intravenous administration of isoproterenol, narrow QRS wave tachycardia was induced by programmed stimulation (S1S2 400/210 ms on the CS 9,10 channel). The circle length (CL) of the initiated tachycardia was 262 ms, with an ambiguous atrial activation sequence; the A wave was earliest on CS 9,10, which was slightly earlier than on CS 1,2, and the A wave was latest on CS 5,6. This implied a focal atrial tachycardia (AT) originating from the roof of the left atrium (LA) (Fig. 1B) . AT lasted for approximately 2 minutes before spontaneously changing into another kind of AT with a different CL (165 ms) and activation sequence; the A wave conducted from CS 9,10 to CS 1,2, implying that it originated from the right atrium (RA) (Fig. 1C) . Finally, AF was induced (Fig. 1D) . This led to the following questions: What were the potential mechanisms of tachycardia in this patient? Does this imply that ATs originating from different areas combined to induce AF? Firstly, a standard CPVI was performed with 3D mapping using the Ensite NavX System (St. Jude Medical; Fig. 2A ). During CPVI, we observed a spontaneous change from an AT with a CL of 303 ms and right to left activation sequence (Fig. 2B ) to an AT with a CL of 278 ms and CS 9,10/1,2 to CS 5,6 activation sequence (Fig. 2C ). In addition, the A wave on CS 1,2 was earlier than on CS 9,10. Finally, the latter AT was stabilized after CPVI.
Activation sequence 3D mapping was performed in the LA. The earliest A wave was located in the roof of the right LA, which was 61 ms earlier than the A wave on CS 9,10 ( Fig. 2D) . However, repeated ablation around the target was invalid (CL and activation sequence were unchanged); therefore, we suspected that the AT originated in the RA.
When we placed the ablation catheter into the SVC, chaotic fibrillation was recorded (Fig. 3A) . In contrast, a LASSO lead (St. Jude Medical) at a slightly lower position (SVC-RA junction) recorded regular activation 91 ms earlier than the CS 9,10 ( Fig. 3B and C) . When the ablation lead was placed at the SVC-RA junction, atrial activation was in the distal to proximal direction (Fig. 3D ). This indicated that activation of the whole atrium originated in the SVC, meaning that AF originating in the SVC was filtered into AT due to weak conduction and blocking of the myocardial sleeve. AT was then terminated when the SVC isolation was completed (Fig. 3E) . 3D mapping showed that the ablation lesions at the SVC-RA joint were adjacent to the earliest point of activation in the LA roof (Fig. 3F ).
Discussion
The incidence of SVC AF is 5% in patients with AF, as reported in studies by Miyazaki et al. [4, 5] The mechanism of AF originating from the SVC is similar to typical PV-related AF, which is known as "muscle sleeve AF." In a report by Desimone et al, [6] cardiomyocyte elongation in the PV was observed in 99% of patients with PV-related AF; in contrast, cardiomyocyte elongation was found in 78% of patients with SVC AF. The EP heterogeneity of the sleeve cells can be arrhythmogenic, resulting in different types of atrial arrhythmia. [7, 8] In this case, AF in the SVC was considered to be the primary cause of arrhythmias; however, it is interesting that several types of AT or AF were observed in this patient. This could be explained by the following points. First, an intracaval conduction delay and decremental conduction properties of the venoarterial (VA) junction is common, as reported by Fukumoto et al. [8] We do not have direct evidence to prove that a relationship exists between AF in the SVC and AT in the atrium; however, the activation sequence shown by the ablation catheter demonstrated that the direction of atrial activation was from the SVC to the atrium. We considered that the conduction delay in the muscle sleeve at the VA junction resulted in filtering of the fibrillation from the SVC to induce AT. Second, the ATs had 2 different conduction directions; one conducted from the RA to the LA through the CS (typical RA originating AT), and the other penetrated the superior part of the atrial septum to activate the roof of the LA first. Third, there was a pathogenetic basis for AF in the LA.
The atrial activation sequence of the first AT after programmed stimulation was a fusion of activations from 2 different conduction directions, as described above. We inferred that conduction via the CS may predominate because the A wave on CS 9,10 was slightly earlier than on CS 1,2. This AT could change to a typical RA originating AT, providing circumstantial evidence to prove our hypothesis. After CPVI, the tachycardia changed; AT with a CL of 278 ms and CS 9,10/1,2 to CS 5,6 activation sequence stabilized. This implied that CS conduction was no longer predominant; from this, we inferred that conduction via the CS may have been weakened by CPVI.
We finally diagnosed the primary lesion as being AF in the SVC in this patient; however, 1 last question arose. In theory, isolating the SVC could terminate tachycardia in this patient; therefore, was CPVI necessary in this patient? As the EP result showed, AF in the SVC was filtered by the muscle sleeve, turning it into AT; clinical AF was induced by the AT, and was terminated by CPVI. This provided evidence that the LA was electrophysiologically unstable in this patient, which was the basis of AF. Furthermore, it implied that there may be one or more arrhythmogenic PVs. Data from Miyazaki et al [5] demonstrated that half of patients with an arrhythmogenic SVC also had an arrhythmogenic PV. Thus, CPVI was necessary to prevent future episodes of AF.
Conclusion
This case report describes an example of AF in the SVC being the primary loci of tachycardia. Because of different conduction directions and electrophysiological vulnerability of the LA, different types of AT were observed in this patient. 
